Algo más sobre la miltefosina en el tratamiento de la leishmaniasis mucosa

García Bustos, María Fernanda; Barrio, Alejandra; Basombrío, Miguel Ángel.
Medicina (B.Aires) ; 75(2): 130-132, abr. 2015.
Artículo en Español | LILACS | ID: lil-750531

Documentos relacionados

  1. [Miltefosine or meglumine antimoniate in leishmaniasis].
  2. [More about miltefosine in the treatment of mucosal leishmaniasis].
  3. [Miltefosine versus meglumine antimoniate in the treatment of mucosal leishmaniasis].
  4. Cutaneous leishmaniasis in Switzerland: first experience with species-specific treatment.
  5. Case Report: Mucosal Leishmaniasis in New York City.
  6. Miltefosina versus antimoniato de meglumina en el tratamiento de la leishmaniasis mucosa
  7. Randomized controlled clinical trial to access efficacy and safety of miltefosine in the treatment of cutaneous leishmaniasis Caused by Leishmania (Viannia) guyanensis in Manaus, Brazil.
  8. [Treatment of visceral leishmaniasis in children].
  9. Miltefosine in cutaneous leishmaniasis.
  10. [Mucosal leishmaniasis by contiguity with a skin lesion: another case report from Tunisia].